Company: HURA
Filing Date: 2025-09-18
Form Type: S-1/A
Source: 0001193125-25-207395
Chunk: 286

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-09-18
Form: S-1/A
Chunk 286
---
 |                               | 1,399.72 |
| Expiry of warrants issued for services |     |                                 | (2 | ) |     |                               | 1,750.00 |
| Balance - September 30, 2024           |     |                                 | 17 |   |     |                               | 1,362.41 |

The following table summarizes the Company’s outstanding common stock warrants as of September 30, 2024:

| Description of warrants      
 2022 April Investor warrants 
 2022 Investor warrants       |     | Number(in thousands) |  9 
  7 |     | Exerciseprice $ |   717.50 
 2,187.50 |     | Expiry date | April 14, 2027   
 March 28, 2025   |
|:-----------------------------|:----|:---------------------|---:|:----|:----------------|---------:|:----|:------------|:-----------------|
| 2022 April Agent warrants    |     |                      |  1 |     |                 | 1,159.20 |     |             | October 14, 2026 |
|                              |     |                      | 17 |     |                 |          |     |             |                  |

<div align='center'>F-4 4</div>

Series C Preferred Stock warrants

In connection with the Series C Preferred Stock private placement, the Company issued 2,504 Series C Agent Warrants. The Series C Agent Warrants had an exercise price of $ 1,000 per share, provide for a cashless exercise feature, and wee exercisable for a period of four years from August 19, 2020. The Series C Agent Warrants expired unexercised on August 19, 2024. The Series C Preferred Stock issuable upon exercise of the Series C Agent Warrants were convertible into shares of common stock in the same manner as each respective underlying series of outstanding Series C Preferred Stock and were entitled to the same dividend rights as each respective series.

The following table sets forth changes in outstanding Series C Agent Warrants:

|                                   |     | BalanceJune 30, 2024 |       |     | Number ofWarrants Expired |        |   |     | Balance,September 30, 2024 |   |     | Conversionprice$ |          |
|:----------------------------------|:----|:---------------------|------:|:----|:--------------------------|: